Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 2/3 5Phase 1 5Phase NA 4Phase 1/2 4Phase 3 3

Status

Recruiting 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Plasma cell 2Myeloid 2Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 1041Neoplasms 872Prostatic Neoplasms 506Lung Neoplasms 421Colorectal Neoplasms 357Motor Activity 219Head and Neck Neoplasms 194Uterine Cervical Neoplasms 189Carcinoma, Non-Small-Cell Lung 180Brain Neoplasms 173Pancreatic Neoplasms 160Ovarian Neoplasms 138Colonic Neoplasms 137Carcinoma, Hepatocellular 136Anxiety Disorders 124Rectal Neoplasms 117Hematologic Neoplasms 114Multiple Myeloma 106Stomach Neoplasms 103Neoplasm Metastasis 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 94Melanoma 92Depression 92Urinary Bladder Neoplasms 88Pain 87Endometrial Neoplasms 86Glioblastoma 84Disease 83Lymphoma 81Sarcoma 78

Interventions

Specimen Handling 1Genetic Testing 1Genetic Counseling 1Follow-Up Studies 1Chromatin Immunoprecipitation Sequencing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Lymphoproliferative Disorders × 1 year × Clear all
NCT07445438 2026-03-03

FOCUS

Azienda Ospedaliero-Universitaria di Parma

Phase NA Recruiting
1,040 enrolled
LymphoidMyeloidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders

NCT07445984 2026-03-03

Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)

Azienda Ospedaliero-Universitaria di Parma

Phase NA Recruiting
250 enrolled
LymphoidMyeloid

Lymphoproliferative Disorders, Myeloproliferative Disorders

NCT05898789 2026-02-25

Virtual Rehabilitation for Cancer Survivors

University Health Network, Toronto

Phase NA Recruiting
388 enrolled
BreastGastrointestinalHead & NeckLymphoid

Breast Carcinoma In Situ, Breast Neoplasms, Head and Neck Neoplasms, Lymphoma, Lymphoproliferative Disorders, Colorectal Neoplasms

NCT06630104 2026-01-08

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Mayo Clinic

Phase NA Recruiting
82 enrolled
LymphoidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡